Its hard to know what to expect with MYX. I am sure investors genuinely believe in the value proposition at the current price. If you look at the price to book it is 0.85 suggesting the company is substantially undervalued. It is very hard to find any meaningful company that is below 1. Many pharma and bio companies are higher than 1 or multiples. Sigma with its own problems is 1.05; API is 1.44; HSO 1.82; RMD 7.26; ANN 1.8; CAJ 1.84. Others are substantially higher. The only explanation for this could be a massive write down coming. Its possible. However, they took a hit on the Teva acquisition already and a non cash charge in the last half. You never know if there are any other skeletons.
The more likely explanation that everyone believes is that the company is well undervalued. With the recent modest improvements in the share price lets hope it is a change in trend.
If you are in Mayne you are in pain, page-30
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.60 |
Change
0.030(0.66%) |
Mkt cap ! $391.3M | |||
| Open | High | Low | Value | Volume |
| $4.59 | $4.62 | $4.51 | $457.1K | 99.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 131 | $4.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.60 | 3549 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MYX (ASX) Chart |